hsCRP Blood Test (High Sensitivity C-Reactive Protein)

An hsCRP blood test can help you:

• Assess low grade inflammation that may be quietly increasing cardiovascular risk, even when cholesterol looks normal.
• Reclassify borderline or intermediate heart risk by clarifying whether inflammation is adding extra load on top of lipid related risk.
• Provide context for other markers such as ApoB, ApoA1, Lp(a), and HbA1c, since inflammation interacts with lipids and metabolism.
• Track how your inflammatory profile changes over time as you adjust nutrition, movement, sleep, and stress.
• Support clinician guided decisions about how aggressively to manage cardiovascular risk and whether additional investigations are needed.

C reactive protein CRP is a protein made by the liver in response to signals from the immune system. It rises when the body is responding to infection, tissue injury, or other inflammatory triggers. Standard CRP tests are designed to detect large rises that occur with acute inflammation.

High sensitivity C reactive protein hsCRP uses a more precise method to detect much lower levels of CRP in the bloodstream. This low level range is typically not about acute infection, but about persistent, low grade inflammation that may reflect vascular inflammation within the artery wall.

Because atherosclerosis is partly an inflammatory process, hsCRP has become a useful marker to help estimate future cardiovascular risk. It does not tell you where inflammation is coming from, but it does help show whether inflammatory signalling is higher than expected for your overall health profile.

hsCRP itself is not a hormone or enzyme, but a marker of the broader inflammatory response. When interpreted correctly, it can:

• Reflect low grade, chronic inflammation that is not obvious from symptoms alone.
• Provide insight into inflammatory activity in arterial walls, which contributes to plaque formation and instability.
• Help distinguish between lower and higher cardiovascular risk in people with similar cholesterol profiles.
• Flag when inflammation is high enough that another cause, such as infection or autoimmune disease, should be considered.

In preventive care, hsCRP is often interpreted in three broad bands for cardiovascular risk:

• Lower risk: hsCRP below around 1 mg/L.
• Intermediate risk: hsCRP around 1 to 3 mg/L.
• Higher risk: hsCRP persistently above around 3 mg/L, once acute triggers have been ruled out.

Heart disease is driven not only by cholesterol and blood pressure, but also by the inflammatory environment in which arteries live. Artery walls that are chronically inflamed are more likely to develop plaques and for those plaques to become unstable.

hsCRP matters because:

• Higher levels are associated with a greater risk of heart attack, stroke, and other cardiovascular events, even after accounting for cholesterol.
• Persistent elevation over several measurements appears more predictive than a single raised value.
• It helps identify people whose cardiovascular risk is higher than their lipid panel alone would suggest, especially in intermediate risk groups.

In practice, hsCRP is particularly useful when:

• You have borderline cholesterol results and your clinician is deciding how intensively to treat.
• You have a strong family history of cardiovascular disease but no obvious risk factors.
• You live with conditions like metabolic syndrome, type 2 diabetes, or autoimmune disease, where inflammation and cardiometabolic health are tightly linked.

It is easy to assume hsCRP and standard CRP are the same test, but they are used for different purposes.

• Standard CRP is designed to detect large increases in CRP, often in the range seen with acute infection, significant injury, or active inflammatory disease. It is commonly used in hospital and acute care settings.
• hsCRP is designed to accurately measure much lower CRP levels, typically in the range associated with low grade inflammation and vascular risk. It is used for cardiovascular risk assessment and long term monitoring.

This distinction matters because:

• A standard CRP test may read as "normal" while hsCRP reveals subtle but persistently elevated inflammation.
• hsCRP is not used to diagnose the cause of inflammation but to help refine cardiovascular risk and track trends over time.

hsCRP reflects a broad mix of lifestyle, metabolic, and medical influences. These are some of the main factors that can raise or lower levels.

1. Acute infection and injury

• Viral or bacterial infections, recent surgery, or significant injuries can raise CRP well above 10 mg/L.
• In this context, an elevated hsCRP is usually explained by the acute trigger rather than long term vascular risk.
• For cardiovascular risk assessment, hsCRP is typically rechecked after acute issues have settled.

2. Chronic low grade inflammation

• Obesity, particularly central abdominal fat, is strongly associated with chronically higher hsCRP.
• Metabolic syndrome and type 2 diabetes often drive persistent low grade inflammation through insulin resistance and fatty liver.
• Chronic inflammatory or autoimmune conditions can also elevate hsCRP, although interpretation then focuses on disease activity as well as cardiovascular risk.

3. Lifestyle factors

• Smoking is a powerful driver of higher hsCRP and vascular inflammation.
• Low physical activity and poor sleep quality can contribute to elevated hsCRP over time.
• Diets high in ultra processed foods, added sugars, and certain trans fats may promote low grade inflammation in some people.

4. Hormones and life stage

• Hormonal transitions such as menopause, pregnancy, and changes in sex hormone levels can influence inflammatory markers.
• Ageing is associated with a gradual rise in inflammatory signals for many people, sometimes referred to as "inflammaging."

5. Medications and supplements

• Some medications, such as statins, appear to reduce hsCRP as well as LDL cholesterol in many individuals.
• Non steroidal anti inflammatory drugs and certain targeted therapies can also affect CRP levels, though they are not prescribed purely to optimise hsCRP for prevention.
• Any new or changed medication should be factored into hsCRP interpretation, especially when you are tracking trends over time.

Yes. hsCRP can be high even when total cholesterol and LDL cholesterol appear within the reference range. This pattern is important because it suggests that inflammation may be adding extra cardiovascular risk independently of lipids.

Common scenarios include:

• People with normal cholesterol but central weight gain, insulin resistance, or early metabolic syndrome.
• Individuals with autoimmune or inflammatory conditions where traditional lipid panels do not fully capture elevated cardiovascular risk.
• People with high Lp(a) or ApoB where inflammation and lipids may interact to compound risk.

In these cases, hsCRP helps identify those who may benefit from more intensive lifestyle intervention and closer cardiovascular follow up.

Laboratories usually report hsCRP as a specific number in mg/L, often with interpretive bands. These bands reflect population risk rather than a hard cut off between safe and unsafe.

From a cardiovascular prevention perspective:

• Lower levels, typically below 1 mg/L, are often considered more favourable.
• Levels between about 1 and 3 mg/L are often viewed as intermediate, where other risk factors become important for context.
• Levels persistently above about 3 mg/L suggest higher cardiovascular risk, once acute infections and short term triggers have been ruled out.

The most appropriate target for hsCRP depends on your overall risk profile. For someone at very high cardiovascular risk, your clinician may aim for an hsCRP that is as low as reasonably achievable alongside lipid, blood pressure, and glucose control.

You usually do not need to fast for an hsCRP test, as CRP levels are not directly influenced by a single meal in the way triglycerides can be. However:

• If your hsCRP is being measured as part of a broader metabolic and lipid panel, fasting may still be recommended for the other markers.
• Your test instructions will clarify whether you should avoid food and caloric drinks for a set number of hours before the blood draw.

Following the preparation guidance helps your healthcare team interpret your results consistently and compare them over time.

Lowering hsCRP focuses on identifying and addressing the sources of inflammation rather than chasing a number in isolation. Depending on your situation, clinician guided strategies may include:

• Improving metabolic health through nutrition, physical activity, and sustainable weight management, particularly targeting central abdominal fat.
• Supporting healthy sleep patterns and stress management, both of which influence inflammatory signalling.
• Stopping smoking and moderating alcohol intake, which can have significant impact on vascular inflammation.
• Investigating and treating underlying conditions such as infections, autoimmune diseases, or inflammatory joint conditions where clinically indicated.
• Using lipid lowering therapies or other cardiometabolic medications when appropriate, which may reduce hsCRP alongside improvements in other markers.

Because hsCRP can fluctuate, some guidelines suggest averaging two results taken at least two weeks apart when using it for cardiovascular risk assessment. Tracking hsCRP over months and years, rather than focusing on a single reading, shows how your inflammatory profile responds to targeted changes.